Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07710846

A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy

The purpose of this Patient Identification and Characterization (PIC) study is to collect information and perform limited allergy-related procedures to determine if participants can qualify for cat and/or birch tree pollen allergy clinical research studies in the future. The study is also looking at how cat and/or birch tree pollen allergies have affected overall health.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Key Inclusion Criteria:

  • Adults or pediatric participants, ≥5 years of age inclusive (pediatric participants ≥5 years and <18 years and weighing ≥10 kg, to be enrolled where permitted per local regulations/approvals), at the time of signing the informed consent
  • Participant-reported (and/or caregiver-reported for pediatric participants) and/or documented allergic history as described in the protocol
  • Positive Skin Prick Test (SPT) at screening: to cat allergen (Part A) and/or to birch allergen (Part B)
  • Must not currently live with a cat(s) or have lived with a cat(s) in the home for the past 1 year (Part A)
  • Willing and able to comply with clinic visit(s) and study-related assessments

Key Exclusion Criteria:

  • Presence of any ophthalmic disease/abnormality/condition that may interfere with study assessments, affect the study outcomes or participant safety as described in the protocol
  • History of life-threatening asthma, defined as an asthma episode that required intubation and/or was associated with hypercapnia, respiratory arrest, and/or hypoxic seizures
  • Active, chronic infections requiring long-term use of systemic antibiotics, antivirals, or anti-fungal treatments

Note: Other Protocol Defined Inclusion/ Exclusion Criteria Apply

Treatment and study plan

Noninterventional

Other

No investigational medicinal products will be administered in this study.

Primary outcomes

  1. Proportion of participants with moderate-to-severe allergic conjunctivitis due to cat allergy who report "very bothered" or "extremely bothered" by allergic symptoms upon exposure to cat and/or cat hair/dander

    Time frame: At visit 1, up to 30 days

    Part A

  2. Proportion of participants with moderate-to-severe allergic conjunctivitis due to birch tree pollen allergy who report "very bothered" or "extremely bothered" by allergic symptoms

    Time frame: At visit 1, up to 30 days

    Part B

Secondary outcomes

  1. Proportion of participants who report "very bothered" or "extremely bothered" by allergic symptoms upon exposure to cat and/or cat hair/dander

    Time frame: At visit 1, up to 30 days

    Part A

  2. Proportions of participants who report "very bothered" or "extremely bothered" by allergic symptoms due to birch tree pollen

    Time frame: At visit 1, up to 30 days

    Part B

Study contacts

Contact information is provided by the study sponsor or research team.

Clinical Trials Administrator

CONTACT

[email protected]

844-734-6643

Sponsors and collaborators

Lead sponsor

Regeneron Pharmaceuticals

Industry

Registry information

Official study title

Patient Identification and Characterization (PIC) Study: A Prospective, Multicenter, Non-Interventional Study to Identify and Characterize Participants With Allergic Conjunctivitis With or Without Allergic Rhinitis Due to Cat and/or Birch Allergy

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jul 17, 2026
Registry last updated
Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.